BioNTech SE is working to adapt its Covid-19 vaccine to address the omicron variant and expects to have a new version ready within 100 days if necessary. BioNTech SE stock jumped 5% in premarket ...
网页链接BioNTech SE is working to adapt its Covid-19 vaccine to address the omicron variant and expects to have a new version ready within 100 days if necessary. BioNTech SE stock jumped 5% in premarket ...
网页链接
精彩评论